4.7 Article

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

Journal

CLINICAL INFECTIOUS DISEASES
Volume 72, Issue 8, Pages 1463-1466

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa933

Keywords

neglected tropical diseases; coronavirus; modeling

Funding

  1. Bill and Melinda Gates Foundation [OPP1184344]
  2. National Institutes of Health (NIH) [R01 EY025350]
  3. Dutch Research Council (NWO) [016.Veni.178.023]
  4. Bill and Melinda Gates Foundation through the Human African Trypanosomiasis Modelling and Economic Predictions for Policy (HAT MEPP) project [OPP1177824]
  5. European Marie Sklodowska-Curie fellowship [H2020-COFUND-2015-FP-707404]
  6. UK Medical Research Council (MRC) [MR/R015600/1]
  7. UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, EDCTP2 program - European Union
  8. NIH [RO1AI123245]
  9. US NIH
  10. MRC [MC_PC_19012, MR/R015600/1] Funding Source: UKRI

Ask authors/readers for more resources

The COVID-19 pandemic has led to the postponement of key neglected tropical disease activities, hindering progress towards the ambitious goals for 2030. Mathematical modelling indicates that the impact of this disruption will vary across different NTDs, with a risk of resurgence being fastest in high-transmission areas.
Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available